Diagnostic HYBRIDS wins Diagnostic Marketing Association Awards for Website, Corporate Identity
Athens, OH – Diagnostic HYBRIDS was presented with two awards at the 2007 DxMA Annual Conference in Chicago, Ill. The company received first place recognition for its new corporate identity, and second place recognition for its new website.
“I am thrilled that Diagnostic HYBRIDS has been chosen to receive this prestigious award,” said Steve Geimer, the company’s vice president of sales, marketing & service. “Our goal 18 months ago was to improve our strategic and tactical marketing capability to drive long-term sustained growth. We have had extremely positive customer feedback on the changes implemented, and when leveraged with our multiple new product launches recently, our aggressive investment has begun to pay big dividends. The recognition from the Diagnostic Marketing Association further validates we are on the right path, and I wish to thank them for drawing attention to Diagnostic HYBRIDS in this way,” Geimer added.
Diagnostic HYBRIDS’ corporate identity was created in collaboration with Paul Werth Associates, a national public relations and marketing communications firm based in Columbus, Ohio. The company’s new logo, affectionately called “hybrid guy,” visually merges a running figure with the distinctive DNA double helix and monoclonal antibody technology, signifying Diagnostic HYBRIDS’ commitment to society, the medical field, and future technologies. The ideal behind the company theme, “Integrating Science and Humanity,” refers to the connection between human talent and innovative cell biology and molecular diagnostic tools that makes the company successful.
"Diagnostic HYBRIDS is a world-leader in the development of innovative diagnostic tools and we congratulate the team on being recognized by the Diagnostic Marketing Association. The goal of our partnership with Diagnostic HYBRIDS was to create a brand identity and message that communicated the company's strong scientific core, while at the same time illustrating its broad impact on humanity," said Bill Kiefaber, vice president for Paul Werth Associates. "Throughout our history working together, one common theme continues to rise to the top - Diagnostic HYBRIDS is a company dedicated to the seamless integration of science and humanity. We believe the brand identity and corporate theme describe the company's global vision as well as its unique culture and perspective on its people and its community."
The company website, designed by MediaBrite LLC of Athens, Ohio, further emphasizes the connection between people and technology by incorporating educational materials for clinicians and laboratory professionals along with information on Diagnostic HYBRIDS’ products.
“I am very proud of the Diagnostic HYBRIDS sales and marketing team and the outstanding agency support provided by Paul Werth Associates of Columbus and MediaBrite of Athens,” said Geimer. “They are a valued part of the promotional element of our marketing strategy and complement the core competencies of Diagnostic HYBRIDS perfectly. This award is due to the efforts of all – I can’t thank them enough for their support,” he added.
The Diagnostic Marketing Association Annual Awards of Excellence honor the finest communications efforts in diagnostics marketing. Annual awards are presented for the in vitro diagnostic industry’s best creative marketing for advertising, collateral, direct mail, corporate communications, corporate identity, interactive education and interactive websites. For more information, visit www.dxma.org.
About Diagnostic HYBRIDS
Headquartered in Athens, Ohio, Diagnostic HYBRIDS invents, develops, manufactures, and sells innovative diagnostic and analytical products for a wide range of viral respiratory diseases, herpes virus infections, and other specific viral and thyroid diseases. The company also develops and commercializes innovative and genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry, with an initial focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines. The company is certified to ISO 13485 standards and manufactures live continuous and primary cell cultures for clinical diagnostics and pharmacology assays from its headquarters in Athens, OH. Diagnostic HYBRIDS was named one of the 500 Fastest Growing Companies in America in 2004 and 2005 by Inc. Magazine. The company is a pillar member of BioOhio, a statewide organization of bioscience companies accelerating the bioscience and healthcare economy in Ohio. For more information, please visit www.dhiusa.com.
Contact:
Christina Dierkes
Coordinator, Marketing Communications & Public Relations
christina_dierkes@dhiusa.com
p: 740-597-2928
